Insights
Discover our latest insights:
When AI Writes Care Notes, Gender Still Shapes the Story
Does artificial intelligence treat men and women the same when it comes to healthcare? A new study suggests the answer depends on which AI you use. Published in BMC Medical…
When a digital scribe becomes a medical device: Where the TGA draws the line
Artificial intelligence is already changing the way healthcare is delivered, but some of the most visible shifts are happening not in diagnosis or treatment…
Breakthrough therapies for Parkinson’s, cancer and more now within reach for patients
For some Australians facing serious illness, the difference between treatment and going without can come down to cost—and instead of six figures…
TGA charts AI future for medical devices with landmark review
Artificial intelligence may never replace a reassuring voice at the bedside, but it is already shaping the way Australians receive healthcare. From diagnostic algorithms to clinical decision support…
Australia’s Mental Health System: Progress in Patches But Pressure Everywhere
The report card on Australia’s mental health system has been released, and while there are glimmers of progress, the findings make clear that the system…
A Billion-Dollar Backing for Aussie Vaccine Science
The importance of vaccines in preventing serious respiratory illness is no secret. But Sanofi’s recent $2.5 billion acquisition of Vicebio also marks a powerful signal of…
The new normal: Nearly 40 per cent of Australians living with multiple chronic conditions
Living with more than one chronic condition is now a daily reality for nearly 40 per cent of Australians — and that number is expected to grow.
Trump Revives Pharma Tariff Threat – What Global Biotech Should Watch For
In a familiar blend of rhetoric and ambiguity, US President Donald Trump has again raised the prospect of imposing sweeping tariffs on foreign-made…
30 Billion Barcodes and a Breakthrough for Biomedical Science
Every human body begins with a single cell. But how that cell divides, specialises and gives rise to the extraordinary complexity of tissues and organs has…
As China Moves Faster on Clinical Trials, Can Australia Keep Pace?
China is once again shifting gears in biotech. Under a new draft policy, the country’s drug regulator is proposing to halve its clinical trial review period for novel medicines—from 60 to just 30 working days.
What the Latest Health Data Tells Us About Closing the Gap
When it comes to Aboriginal and Torres Strait Islander, progress is happening—but it’s not happening fast. That’s the key message from the latest Aboriginal and Torres Strait Islander Health Performance…
Pioneering real-time genomic sequencing to combat superbugs
In a ground-breaking initiative, researchers at the Peter Doherty Institute for Infection and Immunity (Doherty Institute), in collaboration with seven major Victorian hospitals, have successfully…
